Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study

By Gajria Kavita  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite

Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 463-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

By Pascual Maria Luz G.   Fleming Rosa Rosanna B.   Gana Theophilus J.   Vorsanger Gary J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2531-2542

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet® CR), and carbidopa‐levodopa‐entacapone (Stalevo®)

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 995-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study

By Klimberg Ira   Shockey Gerald   Ellison Howard   Fuller-Jonap Freida   Colgan Richard   Song James   Keating Karen   Cyrus Pamela  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1241-1250

Informa Healthcare

Access to resources Recommend Favorite